European Commission Orders Illumina to Sell Cancer-Test Developer Grail
Illumina has filed an appeal at the Court of Justice, the EU’s top court, over the decision that gave the EU authority to review the merger. Illumina is being advised by Cleary Gottlieb Steen & Hamilton; Grail by Latham & Watkins.